Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
Clinical trial NCT07217587 · RECRUITING
Trial details
- NCT number
- NCT07217587
- Sponsor
- Janssen Research & Development, LLC
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-05
- Primary completion
- 2027-09-28
- Enrollment
- 115
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.